Imac logo

Imac(NASDAQ) IMAC

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-100%
5 Year-100%
1 Year-99%
1 Month-17%
N/A
Imac last closing stock price
MetricPriceDate
Last closeUSD 0.002026-10-22
Imac stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-16.67%USD 0.002026-10-15
1 month-16.67%USD 0.002026-09-22
3 month+150%USD 0.002026-07-24
Year to date-99.64%USD 0.142025-12-31
1 year-99.24%USD 0.072025-10-22
3 year-99.97%USD 1.992023-10-23
5 year-100%USD 40.802021-10-22
Since inception-100%USD 110.402019-02-13

Imac Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

-$5.02M

Net Income (TTM)

-$9.28M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Aug 15, 2022

IMAC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imac

IMAC Holdings, Inc. operates a network of advanced medical and regenerative care facilities across the United States. The company focuses on delivering a range of outpatient treatments targeting sports-related injuries, chronic pain, and other soft tissue issues.

Products and Services
  • Regenerative and orthopedic treatments
  • Physical therapy and spinal decompression
  • Chiropractic manipulation services
Growth Outlook
  • Expansion of outpatient clinics in six states
  • Increasing demand for minimally invasive treatments
  • Focus on innovative regenerative medicine solutions
Financial Highlights
  • Recent quarterly revenue of $21,223
  • Trailing twelve months net income of -$3,078,533
  • Current liabilities significantly exceed current assets
IMAC Holdings, Inc. is positioned within the healthcare sector, specifically in the medical care facilities industry. The company has established a presence with 15 outpatient centers, primarily located in Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida. Despite facing financial challenges, including negative net income and high operating expenses, the company continues to focus on expanding its services and improving patient outcomes. The growing interest in regenerative medicine and minimally invasive procedures presents potential opportunities for future growth. Investors may find the company's commitment to innovation and expansion noteworthy as it navigates the complexities of the healthcare market.
AI Generated • Oct 22, 2026

Industry

Healthcare Providers and Services

Employees

15

CEO

Faith Zaslavsky

Headquarters

Brentwood, TN 37027, US

IMAC Financials

Key Financial Metrics (TTM)

Gross Margin

-965.85%

Operating Margin

-18025.78%

Net Income Margin

-24496.06%

Return on Equity

45.60%

Return on Capital

N/A

Return on Assets

-1676.73%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-0.75%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$1.56M

Operating Income

-$1.80M

EBITDA

-$2.59M

Operating Cash Flow

-$519.87M

Capital Expenditure

$474.14K

Free Cash Flow

-$519.40M

Cash & ST Invst.

$45.05K

Total Debt

$0.00

Imac Performance Analysis

Imac annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 14,385,828N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 72,050N/A
Imac sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q12025-03-31100.0%
Q22025-06-30-100.0%
Q32025-09-30N/A
Imac annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -14.02N/A
20222022-12-31USD -458.193167.2%
20232023-12-31USD -7.48-98.4%
20242024-12-31USD -7.702.9%
Imac sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31N/A
Q12025-03-31-1442.9%
Q22025-06-3017.6%
Q32025-09-30-29.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$21.22K

-99.6%

Gross Profit

-$102.65K

-108.2%

Gross Margin

-4.84%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

154

N/A

Net Income

-$3.08M

-262.8%

EBITDA

$52.19K

+103.7%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$45.05K

-100.0%

Total Debt

$0.00

-100.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$0.00

-100.0%

Return on Assets

-16.77%

N/A

Return on Invested Capital

29.48%

N/A

Free Cash Flow

-$1.42M

-100.3%

Operating Cash Flow

-$1.42M

-100.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GRCEGrace Therapeutics, Inc.
$1.77-8.29%
IRDOpus Genetics, Inc.
$3.26-6.20%
SHLTSHL Telemedicine Ltd.
$2.05+0.99%
AKLIAkili, Inc.
$0.43+0.25%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.60-16.92%
EWZiShares - iShares Msci Brazil ETF
$33.91-20.38%
ITUBItaú Unibanco
$7.66-20.79%
XPXP
$15.40-49.38%

Questions About IMAC

What is the current price of Imac?

Imac is trading at N/A per share.

What is the 52-week range for Imac?

Over the past 52 weeks, Imac has traded between N/A and N/A.

How much debt does Imac have?

As of the most recent reporting period, Imac reported total debt of $3.83M.

How much cash does Imac have on hand?

Imac reported $45.05K in cash and cash equivalents in its most recent financial results.

What is Imac’s dividend yield?

Imac does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.